Bei Zhang1, Yong-Quan Shi2, Jun-Jie Zou1, Xiang-Fang Chen1, Wei Tang1, Fei Ye1, Zhi-Min Liu1. 1. Department of Endocrinology, Shanghai Changzheng Hospital, No. 415, Fengyang Road, Huangpu District, Shanghai, 200003, People's Republic of China. 2. Department of Endocrinology, Shanghai Changzheng Hospital, No. 415, Fengyang Road, Huangpu District, Shanghai, 200003, People's Republic of China. shiyqwz@163.com.
Abstract
PURPOSE: The present study investigated the putative mechanisms underlying effects of KATP channel on high glucose (HG)-induced mesangial cell proliferation and tissue inhibitors of metalloproteinases (TIMP)-2 and Collagen IV production. METHODS: Rat mesangial cells were subjected to whole cell patch clamp to record the KATP channel currents under high glucose (HG, 30 mM) condition. Cell proliferation was measured using a CCK-8 assay. The production of TIMP-2 and Collagen IV and AMP-activated protein kinase (AMPK)-signaling pathway activity was assessed by ELISA and Western blotting, respectively. AMPK agonist (AICAR) was used to analyze the role of this kinase. The expression of KATP subunit (Kir6.1, Kir6.2, SUR1, SUR2A and SUR2B) was examined using quantitative real-time PCR (RT-PCR). RESULTS: We found that HG was significant decreases in the expression of Kir6.1, SUB2A and SUB2B, three subunits of KATP, TIMP-2 production, KATP channel activity and AMPK activity, while it promoted the cell proliferation and Collagen IV production in rat mesangial cells. Pretreatment with KATP selective opener (diazoxide, DZX) significantly inhibited HG-induced mesangial cell proliferation, Collagen IV production and decrease in KATP channel activity in rat mesangial cells, which were reversed by pretreatment of 5-hydroxydecanoate, a selective inhibitor of KATP. Moreover, AICAR pretreatment inhibited HG-induced decrease in KATP channel activity. CONCLUSIONS: Taken together, activating AMPK-KATP signaling may protect against HG-induced mesangial cell proliferation and Collagen IV production, and, thereby, provides new insights into the molecular mechanisms underlying early diabetic nephropathy (DN).
PURPOSE: The present study investigated the putative mechanisms underlying effects of KATP channel on high glucose (HG)-induced mesangial cell proliferation and tissue inhibitors of metalloproteinases (TIMP)-2 and Collagen IV production. METHODS:Rat mesangial cells were subjected to whole cell patch clamp to record the KATP channel currents under high glucose (HG, 30 mM) condition. Cell proliferation was measured using a CCK-8 assay. The production of TIMP-2 and Collagen IV and AMP-activated protein kinase (AMPK)-signaling pathway activity was assessed by ELISA and Western blotting, respectively. AMPK agonist (AICAR) was used to analyze the role of this kinase. The expression of KATP subunit (Kir6.1, Kir6.2, SUR1, SUR2A and SUR2B) was examined using quantitative real-time PCR (RT-PCR). RESULTS: We found that HG was significant decreases in the expression of Kir6.1, SUB2A and SUB2B, three subunits of KATP, TIMP-2 production, KATP channel activity and AMPK activity, while it promoted the cell proliferation and Collagen IV production in rat mesangial cells. Pretreatment with KATP selective opener (diazoxide, DZX) significantly inhibited HG-induced mesangial cell proliferation, Collagen IV production and decrease in KATP channel activity in rat mesangial cells, which were reversed by pretreatment of 5-hydroxydecanoate, a selective inhibitor of KATP. Moreover, AICAR pretreatment inhibited HG-induced decrease in KATP channel activity. CONCLUSIONS: Taken together, activating AMPK-KATP signaling may protect against HG-induced mesangial cell proliferation and Collagen IV production, and, thereby, provides new insights into the molecular mechanisms underlying early diabetic nephropathy (DN).
Entities:
Keywords:
AMP-activated protein kinase; Cell proliferation; Collagen IV; High glucose; KATP channel
Authors: Nicolae M Panduru; Markku Saraheimo; Carol Forsblom; Lena M Thorn; Daniel Gordin; Johan Wadén; Nina Tolonen; Angelika Bierhaus; Per M Humpert; Per-Henrik Groop Journal: Diabetes Care Date: 2015-02-26 Impact factor: 19.112
Authors: Gabriela da Silva Xavier; Isabelle Leclerc; Aniko Varadi; Takashi Tsuboi; S Kelly Moule; Guy A Rutter Journal: Biochem J Date: 2003-05-01 Impact factor: 3.857
Authors: Inge Tency; Hans Verstraelen; Ivo Kroes; Gabriële Holtappels; Bruno Verhasselt; Mario Vaneechoutte; Rita Verhelst; Marleen Temmerman Journal: PLoS One Date: 2012-11-08 Impact factor: 3.240
Authors: C Beall; D L Hamilton; J Gallagher; L Logie; K Wright; M P Soutar; S Dadak; F B Ashford; E Haythorne; Q Du; A Jovanović; R J McCrimmon; M L J Ashford Journal: Diabetologia Date: 2012-07-04 Impact factor: 10.122